LGBT Cancer Project

Breast Cancer Clinical Trials

A listing of Breast Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35249

A clinical research study of VT-464; given orally once daily in 28 day cycles, Advanced Breast Cancer

UPDATED

Mobile Alabama 36608

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Mobile Alabama 36604

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

Alaska

UPDATED

Anchorage Alaska 99508

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Anchorage Alaska 99508

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

Arizona

UPDATED

Phoenix Arizona 85054

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Yuma Arizona 85364

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane and Everolimus for the treatment of Breast Neoplasms, Metastatic Breast Cancer

Arkansas

UPDATED

Fayetteville Arkansas 72703

A Phase 2 clinical study for patients with Non Small Cell Lung Cancer or Breast Cancer

California

NEW

Research Center
Additional Locations California

A Phase III Randomized, Double-blind, Placebo-controlled Trial Comparing Capecitabine Plus Sorafenib Versus Capecitabine Plus Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer

UPDATED

Greenbrae California 94904

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Greenbrae California 94904

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

La Jolla California 92093

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

La Jolla California 92093

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane and Everolimus for the treatment of Breast Neoplasms, Metastatic Breast Cancer

UPDATED

Laguna Hills California 92653

A clinical trial to evaluate treatments using MIRA device imaging for patients with Breast Cancer

UPDATED

Long Beach California 90813

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane and Everolimus for the treatment of Breast Neoplasms, Metastatic Breast Cancer

UPDATED

Los Angeles California 90048

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Oakland California 94611

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Palo Alto California 94301

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Roseville California 95661

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Sacramento California 95825

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

San Diego California 92093

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

San Diego California 92123

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

San Diego California 92120

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

San Francisco California 94115

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

San Francisco California 94115

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

San Francisco California 94115

A Phase 2 clinical study for patients with Non Small Cell Lung Cancer or Breast Cancer

UPDATED

San Leandro California 94577

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Santa Clara California 95051

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

South San Francisco California 94080

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Stanford California 94305

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Vallejo California 94589

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Walnut Creek California 94596

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

Colorado

UPDATED

Aurora Colorado 80045

A clinical research study of VT-464; given orally once daily in 28 day cycles, Advanced Breast Cancer

UPDATED

Aurora Colorado 80045

A Phase 2 clinical study for patients with Non Small Cell Lung Cancer or Breast Cancer

UPDATED

Denver Colorado 80222

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Lakewood Colorado 80228

A clinical research study of VT-464; given orally once daily in 28 day cycles, Advanced Breast Cancer

Connecticut

UPDATED

Hartford Connecticut 06102

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

New Britain Connecticut 06053

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

New Haven Connecticut 06510

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane and Everolimus for the treatment of Breast Neoplasms, Metastatic Breast Cancer

Delaware

UPDATED

Newark Delaware 19718

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

District of Columbia

UPDATED

Washington District of Columbia 20037

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Washington District of Columbia 20007

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

Florida

NEW

Research Center
Additional Locations Florida

A Phase III Randomized, Double-blind, Placebo-controlled Trial Comparing Capecitabine Plus Sorafenib Versus Capecitabine Plus Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer

UPDATED

Clearwater Florida 33756

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Fort Myers Florida 33916

A clinical research study of VT-464; given orally once daily in 28 day cycles, Advanced Breast Cancer

UPDATED

Hollywood Florida 33021

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane and Everolimus for the treatment of Breast Neoplasms, Metastatic Breast Cancer

UPDATED

Jacksonville Florida 32224

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Miami Florida 33136

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Miami Beach Florida 33140

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer

UPDATED

Orlando Florida 32804

A clinical trial to evaluate treatments using Palbociclib and Standard Adjuvant Endocrine Therapy for patients with Breast Cancer, (HER2)-Negative Early Breast Cancer